Abstract
Visceral leishmaniasis (VL) is a serious and fatal disease. Therapeutic drugs are toxic and non-sterilizing. The etiological agents Leishmania infantum and Leishmania donovani cause active and asymptomatic diseases. Effective drugs to treat VL exist but unfortunately, post-treatment relapses are common. Little is known why drugs are non-sterilizing or how these intracellular pathogens can escape treatment. Here, using a murine model of VL we found that CD271+/Sca1+ bone marrow mesenchymal stem cells (BM-MSCs) are readily infected in vitro and in vivo by L. infantum. Because BM-MSCs express potent drug efflux pumps, e.g., ABCG2 it is possible that this unique intracellular infectious niche could allow L. infantum to escape anti-parasite drugs.
MeSH terms
-
Animals
-
Disease Models, Animal
-
Humans
-
Leishmania infantum / pathogenicity*
-
Leishmaniasis, Visceral / metabolism
-
Leishmaniasis, Visceral / parasitology*
-
Leishmaniasis, Visceral / pathology*
-
Male
-
Mesenchymal Stem Cells / metabolism
-
Mesenchymal Stem Cells / parasitology*
-
Mesenchymal Stem Cells / pathology
-
Mice
-
Mice, Inbred C57BL
-
Receptors, Nerve Growth Factor / metabolism
-
Stem Cell Niche
Substances
-
Receptors, Nerve Growth Factor
-
Ngfr protein, mouse
Grants and funding
This work was supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), a Brazilian Government for Education and Scientific Research - Fellowship awarded to CSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.